Funding for this research was provided by:
Text and Data Mining valid from 2018-08-15
Received: 2 June 2018
Accepted: 10 July 2018
First Online: 15 August 2018
Ethics approval and consent to participate
: All trial included in the meta-analysis enrolled patients providing informed consent and had approval from their institutional review boards.
: Not applicable.
: BioMérieux Inc. provided an unrestricted research grant to conduct this analysis. However, no personnel from the company were involved in the conduct of the analysis or in the preparation of the manuscript. PS and BM have received support from Thermo-Fisher and BioMérieux to attend meetings and fulfill speaking engagements. BM has also served as a consultant to BioMérieux and Thermo-Fisher. SS has received lecture fees and research support from Thermo-Fisher. CEL has received lecture fees from Brahms and Merck Sharp & Dohme-Chibret. JC has received consulting and lecture fees from Pfizer, Brahms, Wyeth, Johnson & Johnson, Nektar-Bayer, and Arpida. MW has received consulting and lectures fees from Merck Sharp & Dohme-Chibret, Janssen-Cilag, Gilead, Astellas, Sanofi, and Thermo-Fisher. YS has received unrestricted research grants from Thermo-fisher, BioMérieux, Orion Pharma, and Pfizer. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.